uPA Receptor, Human, Recombinant <Urokinase-Type Plasminogen Activator Receptor>

データシート

• 商品コード：807-UK-100
• メーカー：RSD
• 包装：100μg
• 価格： ¥95,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Memarzadeh S et al. Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer. Proc. Natl. Acad. Sci. U.S.A. 2002 Aug;99(16):10647-52
  Memarzadeh S et al
  2002/01/01
  
• 備考：
  Application: Control
• 参照：
  

• No.： 2
• 文献情報：
  Jo M et al. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling. J. Biol. Chem. 2003 Nov;278(47):46692-8
  Jo M et al
  2003/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 3
• 文献情報：
  Joseph K et al. Interaction of high molecular weight kininogen binding proteins on endothelial cells. Thromb. Haemost. 2004 Jan;91(1):61-70
  Joseph K et al
  2004/01/01
  
• 備考：
  Species: Human, Application: Competitive Binding Assay, Dot blot, Sample type: recombinant Cytokeratin 1 and gC1QR, recombinant Cytokeratin 1
• 参照：
  

• No.： 4
• 文献情報：
  Wysoczynski M et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005 Jan;105(1):40-8
  Wysoczynski M et al
  2005/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 5
• 文献情報：
  Ide H et al. Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells. Biochem. Biophys. Res. Commun. 2008 May;369(2):292-6
  Ide H et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Bioassay, Whole Cells
• 参照：
  

• No.： 6
• 文献情報：
  Schar CR et al. A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity. J. Biol. Chem. 2008 Apr;283(16):10297-309
  Schar CR et al
  2008/01/01
  
• 備考：
  Species: Human, Application: Binding Assay, recombinant uPA
• 参照：
  

• No.： 7
• 文献情報：
  Krautkr辰mer E et al. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J. Virol. 2008 May;82(9):4257-64
  Krautkr辰mer E et al
  2008/01/01
  
• 備考：
  Species: viral, Application: Blocking, Hantaan Virus
• 参照：
  

• No.： 8
• 文献情報：
  Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
  Gonzalez RM et al
  2008/01/01
  
• 備考：
  Application: ELISA Standard, Sample Type: N/A
• 参照：
  

• No.： 9
• 文献情報：
  Portelli MA et al. Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. FASEB J. 2014 Feb;28(2):923-34
  Portelli MA et al
  2014/01/01
  
• 備考：
  Application: Cleavage, Sample Type: Protease in buffer
• 参照：
  

• No.： 10
• 文献情報：
  Zhuang T et al. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration. BMC Cancer 2013;13:590
  Zhuang T et al
  2013/01/01
  
• 備考：
  Application: Media Supplement - Cell Prep, Sample Type: whole cells
• 参照：
  

• No.： 11
• 文献情報：
  Huang J et al. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis. BMC Med 2014;12:81
  Huang J et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：